Introduction {#sec1_1}
============

Malignant fibrous histiocytoma (MFH) was first described in 1964 \[[@B1]\]. MFH of the spine was first reported in 1976 \[[@B2]\]. MFH is diagnosed in 1/4 of patients in sarcoma clinical trials and mostly occurs in extremities and soft tissues of the trunk \[[@B3]\].

MFH of the spine is rare and has a much worse prognosis \[[@B4]\]. The diagnosis of MFH requires immunohistochemistry tests revealing no line of differentiation and is considered a diagnosis of exclusion \[[@B5]\]. We report a case of MFH in the thoracic spine, which presented with spinal cord compression and multiple bone metastases and was managed with good results with radiation, embolization, and palliative surgery.

Case Report {#sec1_2}
===========

A 60-year-old man with a history of brain infarction and diabetes mellitus was referred to us with a suspicion of spinal cord injury after a fall. At the time of admission he had Frankel C grade paraparesis and urinary retention. Magnetic resonance imaging (MRI), computer tomography (CT), and positron emission tomography scan disclosed a tumor measuring 7 cm in the largest dimension at the Th8 right costal junction with bone destruction, and spinal canal invasion (Fig. [1](#F1){ref-type="fig"}), L2 vertebral body, right 10th rib and right femur metastasis were also found. Informed consent for treatment was obtained from the patient and his family. Emergency irradiation to the Th8 tumor of 8 Gy/1 Fr was administered and Th7, 8, 9 segmental artery embolization was performed. The patient was operated on the 6th day from admission after his clopidogrel withdrawal period. Percutaneous biopsy from L2 vertebral body was performed followed by Th7, 8, 9 laminectomy and removal of the tumor mass invading the spinal canal. There were no adhesions between tumor and nerve tissue. Intraoperative bleeding was negligible.

Pathology of the Th8 tumor revealed pleomorphic cells with dispersed spindle cells, Mib-1 index \>20%, p53 diffusely positive (Fig. [2](#F2){ref-type="fig"}). A small number of cells was S-100 positive. Additional immunohistochemistry revealed AE1/AE3(−), aSMA(−), STAT6(−), CD34(−), PgR(−), NapsinA(−), TTF-1(−), CD68(+), cKit(−), GFAP(−).

L2 pathology was S-100(−) and showed less polymorphism.

Next, percutaneous instrumentation from L1 to L3 was performed for impending pathological fracture of L2 after 8 Gy/1 Fr irradiation to L2 body metastasis. Intramedullary nailing was performed for impending pathological fracture of the right femur after 24 Gy/4 Fr irradiation.

The postoperative course was benign. Paraparesis gradually improved to Frankel D within 3 months. The patient regained the ability to ambulate with a walker and normal urinary function.

The right 10th rib metastasis was controlled with a course of 66 Gy/33 Fr resulting in tumor shrinking.

Th8 tumor at this point shrank to 2 cm on MRI (Fig. [3](#F3){ref-type="fig"}). L2 and right femur metastases showed no progression. The patient was discharged home and had an uneventful course for 1 year when he suddenly developed a submandibular abscess unrelated to his malignancy. He was admitted to a local hospital and surgically treated but died of sepsis 22 months after the MFH diagnosis.

Discussion {#sec1_3}
==========

MFH of the spine is slow growing and might not manifest itself until nerve compression or a pathological fracture occurs. Bone destruction is characteristically not accompanied by periosteal reaction or new bone formation \[[@B4]\]. Treatment includes irradiation, embolization, and surgery with en-bloc resection being the only curative option \[[@B4], [@B6]\]. It is known that MFH can be transplanted to the surgeon during operation \[[@B7]\] so special precautions are recommended. Chemotherapy is still controversial.

The mean life expectancy is 33 months after en-bloc resection and 15 months with palliative management \[[@B4]\].

Conclusion {#sec1_4}
==========

We report a rare case of thoracic spine MFH with multiple bone metastases and spinal cord compression successfully managed with multidisciplinary therapy. The primary tumor shrunk significantly and did not grow again. The patient survived for 22 months with a good quality of life. To our knowledge, this is the longest survival reported for MFH of the spine presenting with spinal cord compression and treated palliatively.
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![Axial view of Th8 right rib junction tumor. **A** MRI T1. **B** MRI T2. **C** MRI fat suppression. **D** CT showing bone destruction without periosteal reaction or new bone formation.](cro-0013-0012-g01){#F1}

![**A** H&E stain. ×20 magnification. **B** H&E stain. ×200 magnification showing whorls of undifferentiated cells with atypical nuclei. **C** CD68 immunohistochemistry. ×400 magnification showing diffusely positively stained cells.](cro-0013-0012-g02){#F2}

![Th8 tumor MRI T2 sagittal (**A**) and axial (**B**) slice at 1 year postoperatively showing significant tumor shrinking after irradiation, embolization, and partial resection.](cro-0013-0012-g03){#F3}
